Su, H., Yang, F., Fu, R., Trinh, B., Sun, N., Liu, J., ... & Karin, M. (2022). Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature, 610(7931), 366-72.

Filliol, A., Saito, Y., Nair, A., Dapito, D.H., Yu, L.X., Ravichandra, A., ... & Schwabe, R.F. (2022). Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature, 610(7931), 356-65.

Saha, S., Moon, H.R., Han, B., & Mugler, A. (2022). Deduction of signaling mechanisms from cellular responses to multiple cues. NPJ systems biology and applications, 8(1), 48.

Moon, H.R., Saha, S., Mugler, A., & Han, B. (2023). Cells function as a ternary logic gate to decide migration direction under integrated chemical and fluidic cues. Lab on a chip, 23(4), 631-44.

Carpenter, E.S., Elhossiny, A.M., Kadiyala, P., Li, J., McGue, J., Griffith, B., ... & Di Magliano, M.P. (2023). Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early pre-neoplastic pancreatic lesions. bioRxiv : the preprint server for biology, 2023.01.13.523300.

Menjivar, R.E., Nwosu, Z.C., Du, W., Donahue, K.L., Hong, H.S., Espinoza, C., ... & Pasca di Magliano, M. (2023). Arginase 1 is a key driver of immune suppression in pancreatic cancer. eLife, 12, e80721.

Ventre, K.S., Roehle, K., Bello, E., Bhuiyan, A.M., Biary, T., Crowley, S.J., ... & Dougan, S.K. (2023). cIAP1/2 Antagonism Induces Antigen-Specific T Cell-Dependent Immunity. Journal of immunology (Baltimore, Md. : 1950), 210(7), 991-1003.

Cephas, A.T., Hwang, W.L., Maitra, A., Parnas, O., & DelGiorno, K.E. (2023). It is better to light a candle than to curse the darkness: single-cell transcriptomics sheds new light on pancreas biology and disease. Gut, 72(6), 1211-9.

Carpenter, E.S., Elhossiny, A.M., Kadiyala, P., Li, J., McGue, J., Griffith, B.D., ... & Pasca di Magliano, M. (2023). Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions. Cancer discovery, 13(6), 1324-45.

Young, A.M., Van Buren, S., & Rashid, N.U. (2024). Differential transcript usage analysis incorporating quantification uncertainty via compositional measurement error regression modeling. Biostatistics (Oxford, England), 25(2), 559-76.

Halbrook, C.J., Lyssiotis, C.A., Pasca di Magliano, M., & Maitra, A. (2023). Pancreatic cancer: Advances and challenges. Cell, 186(8), 1729-54.

Shen, Y., Yuk, S.A., Kwon, S., Tamam, H., Yeo, Y., & Han, B. (2023). A timescale-guided microfluidic synthesis of tannic acid-FeIII network nanocapsules of hydrophobic drugs. Journal of controlled release : official journal of the Controlled Release Society, 357, 484-97.

Liu, S.Y., Mulugeta, N., Dougan, S.K., & Qiang, L.(in press). In vitro flow cytometry assay to assess primary human and mouse macrophage phagocytosis of live cells. STAR protocols. doi:10.1016/j.xpro.2023.102240

Mijit, M., Boner, M., Cordova, R.A., Gampala, S., Kpenu, E., Klunk, A.J., ... & Fishel, M.L. (2023). Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment. Frontiers in medicine, 10, 1146115.

Qiang, L., Hoffman, M.T., Ali, L.R., Castillo, J.I., Kageler, L., Temesgen, A., ... & Dougan, S.K. (2023). Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy. Gastroenterology, 165(4), 874-890.e10.

Gupta, K., Moon, H.R., Chen, Z., Han, B., Green, N.G., & Wereley, S.T. (2023). Optically induced electrothermal microfluidic tweezers in bio-relevant media. Scientific reports, 13(1), 9819.

Cardot-Ruffino, V., Bollenrucher, N., Delius, L., Wang, S.J., Brais, L.K., Remland, J., ... & Dougan, S.K. (2023). G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. Journal for immunotherapy of cancer, 11(6), e006589.

Affo, S., Filliol, A., Gores, G.J., & Schwabe, R.F. (2023). Fibroblasts in liver cancer: functions and therapeutic translation. The lancet. Gastroenterology & hepatology, 8(8), 748-59.

Leary, J.R., Xu, Y., Morrison, A.B., Jin, C., Shen, E.C., Kuhlers, P.C., ... & Peng, X.L. (2023). Sub-Cluster Identification through Semi-Supervised Optimization of Rare-Cell Silhouettes (SCISSORS) in single-cell RNA-sequencing. Bioinformatics (Oxford, England), 39(8), btad449.

Joisa, C.U., Chen, K.A., Beville, S., Stuhlmiller, T., Berginski, M.E., Okumu, D., ... & Gomez, S.M. (2023). Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies. bioRxiv : the preprint server for biology, 2023.08.01.551346.

Cheng, C., Deneke, N., Moon, H.R., Choi, S.R., Ospina-Muñoz, N., Elzey, B.D., ... & Han, B. (2023). Inkjet-printed morphogenesis of tumor-stroma interface using bi-cellular bioinks of collagen-poly(N-isopropyl acrylamide-co-methyl methacrylate) mixture. Materials today. Advances, 19, 100408.

Su, H., & Karin, M. (2024). Multifaceted collagen-DDR1 signaling in cancer. Trends in cell biology, 34(5), 406-15.

Rogers, S., Zhang, C., Anagnostidis, V., Liddle, C., Fishel, M.L., Gielen, F., & Scholpp, S. (2023). Cancer-associated fibroblasts influence Wnt/PCP signaling in gastric cancer cells by cytoneme-based dissemination of ROR2. Proceedings of the National Academy of Sciences of the United States of America, 120(39), e2217612120.

Carpenter, E.S., Kadiyala, P., Elhossiny, A.M., Kemp, S.B., Li, J., Steele, N.G., ... & Pasca Di Magliano, M. (2024). KRT17high/CXCL8+ Tumor Cells Display Both Classical and Basal Features and Regulate Myeloid Infiltration in the Pancreatic Cancer Microenvironment. Clinical cancer research : an official journal of the American Association for Cancer Research, 30(11), 2497-513.

Silva, L.L., Stratford, R.E., Messmann, R., Kelley, M.R., & Quinney, S.K. (2024). Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330. CPT: pharmacometrics & systems pharmacology, 13(1), 106-17.

Li, K., Huo, Q., Minami, K., Tamari, K., Ogawa, K., Na, S., ... & Yokota, H. (2023). Exploring the Tumor-Suppressing Potential of PSCA in Pancreatic Ductal Adenocarcinoma. Cancers, 15(20), 4917.

Cui, C., Huo, Q., Xiong, X., Li, K., Fishel, M.L., Li, B., & Yokota, H. (2023). Anticancer Peptides Derived from Aldolase A and Induced Tumor-Suppressing Cells Inhibit Pancreatic Ductal Adenocarcinoma Cells. Pharmaceutics, 15(10), 2447.

Decker-Farrell, A.R., Ma, A., Li, F., Muir, A., & Olive, K.P. (2023). Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants. STAR protocols, 4(4), 102711.

Hasselluhn, M.C., Decker-Farrell, A.R., Vlahos, L., Thomas, D.H., Curiel-Garcia, A., Maurer, H.C., ... & Olive, K.P. (2024). Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Cancer discovery, 14(2), 348-61.

Chowdhury, N.N., Yang, Y., Dutta, A., Luo, M., Wei, Z., Abrahams, S.R., ... & Flick, M.J. (2024). Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. Molecular oncology, 18(1), 113-35.

Kureshi, R., Bello, E., Kureshi, C.T.S., Walsh, M.J., Lippert, V., Hoffman, M.T., ... & Dougan, S.K. (2023). DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunity. Science advances, 9(47), eadk1853.

Barravecchia, I., Lee, J.M., Manassa, J., Magnuson, B., Ferris, S.F., Cavanaugh, S., ... & Galban, S. (2024). Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice. Molecular cancer research : MCR, 22(3), 295-307.

Joisa, C.U., Chen, K.A., Berginski, M.E., Golitz, B.T., Jenner, M.R., Herrera Loeza, G., ... & Gomez, S.M. (2023). Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors. PeerJ, 11, e16342.

Katz, M.H.G., Petroni, G.R., Bauer, T., Reilley, M.J., Wolpin, B.M., Stucky, C.C., ... & Rahma, O. (2023). Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma. Journal for immunotherapy of cancer, 11(12), e007586.

Mijit, M., Kpenu, E., Chowdhury, N.N., Gampala, S., Wireman, R., Liu, S., ... & Kelley, M.R. (2024). In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer. Redox biology, 69, 102977.

Shen, Y., Gwak, H., & Han, B. (2024). Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics. The Analyst, 149(3), 614-37.

Wasko, U.N., Jiang, J., Curiel-Garcia, A., Wang, Y., Lee, B., Orlen, M., ... & Olive, K.P. (2023). Tumor-selective effects of active RAS inhibition in pancreatic ductal adenocarcinoma. bioRxiv : the preprint server for biology, 2023.12.03.569791.

Schaefer, A., Hodge, R.G., Zhang, H., Hobbs, G.A., Dilly, J., Huynh, M.V., ... & Der, C.J. (2023). RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling. Science signaling, 16(816), eadg5289.

Griffith, B.D., Lazarus, J., McGue, J., Krishnan, S., D'Angelica, M.I., Shia, J., ... & Frankel, T.L. (2023). Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer. Frontiers in immunology, 14, 1289402.

Joisa, C.U., Chen, K.A., Beville, S., Stuhlmiller, T., Berginski, M.E., Okumu, D., ... & Gomez, S.M. (2024). Combined kinome inhibition states are predictive of cancer cell line sensitivity to kinase inhibitor combination therapies. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 29, 276-90.

Moon, H.R., Surianarayanan, N., Singh, T., & Han, B. (2023). Microphysiological systems as reliable drug discovery and evaluation tools: Evolution from innovation to maturity. Biomicrofluidics, 17(6), 061504.

Benitz, S., Steep, A., Nasser, M., Preall, J., Mahajan, U.M., McQuithey, H., ... & Crawford, H.C. (2024). ROR2 regulates cellular plasticity in pancreatic neoplasia and adenocarcinoma. bioRxiv : the preprint server for biology, 2023.12.13.571566.

Gomez, S.M., Axtman, A.D., Willson, T.M., Major, M.B., Townsend, R.R., Sorger, P.K., & Johnson, G.L. (2024). Illuminating function of the understudied druggable kinome. Drug discovery today, 29(3), 103881.

Kearney, J.F., Trembath, H.E., Chan, P.S., Morrison, A.B., Xu, Y., Luan, C.F., ... & Yeh, J.J. (2024). Myofibroblastic cancer-associated fibroblast subtype heterogeneity in pancreatic cancer. Journal of surgical oncology, 129(5), 860-8.

Antonucci, L., & Karin, M. (2024). The Past and Future of Inflammation as a Target to Cancer Prevention. Cancer prevention research (Philadelphia, Pa.), 17(4), 141-55.

Huffman, B.M., Singh, H., Ali, L.R., Horick, N., Wang, S.J., Hoffman, M.T., ... & Cleary, J.M. (2024). Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. Journal for immunotherapy of cancer, 12(1), e008436.

Gampala, S., Moon, H.R., Wireman, R., Peil, J., Kiran, S., Mitchell, D.K., ... & Fishel, M.L. (2024). New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types. Pharmacological research, 201, 107092.

Aney, K.J., Jeong, W.J., Vallejo, A.F., Burdziak, C., Chen, E., Wang, A., ... & Nissim, S. (2024). Novel Approach for Pancreas Transcriptomics Reveals the Cellular Landscape in Homeostasis and Acute Pancreatitis. Gastroenterology, 166(6), 1100-13.

Salas-Escabillas, D.J., Hoffman, M.T., Moore, J.S., Brender, S.M., Wen, H.J., Benitz, S., ... & Crawford, H.C. (2024). Tuft cells transdifferentiate to neural-like progenitor cells in the progression of pancreatic cancer. bioRxiv : the preprint server for biology, 2024.02.12.579982.

Enzler, T., Shi, J., McGue, J., Griffith, B.D., Sun, L., Sahai, V., ... & Frankel, T.L. (2024). A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions. International journal of molecular sciences, 25(5), 2953.

Heiling, H.M., Rashid, N.U., Li, Q., Peng, X.L., Yeh, J.J., & Ibrahim, J.G. (2024). Efficient computation of high-dimensional penalized generalized linear mixed models by latent factor modeling of the random effects. Biometrics, 80(1), ujae016.

Kirchoff, K.E., Wellnitz, J., Hochuli, J.E., Maxfield, T., Popov, K.I., Gomez, S., & Tropsha, A. (2024). Utilizing Low-Dimensional Molecular Embeddings for Rapid Chemical Similarity Search. Advances in information retrieval : ... European Conference on IR Research, ECIR ... proceedings. European Conference on IR Research, 14609, 34-49.

Wasko, U.N., Jiang, J., Dalton, T.C., Curiel-Garcia, A., Edwards, A.C., Wang, Y., ... & Olive, K.P. (2024). Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer. Nature, 629(8013), 927-36.

Asquith, C.R.M., East, M.P., Laitinen, T., Alamillo-Ferrer, C., Hartikainen, E., Wells, C.I., ... & Johnson, G.L. (2024). Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationships. European journal of medicinal chemistry, 271, 116357.

Peng, X.L., Kharitonova, E.V., Xu, Y., Kearney, J.F., Luan, C., Chan, P.S., ... & Yeh, J.J. (2024). Determination of permissive and restraining cancer-associated fibroblast (DeCAF) subtypes. bioRxiv : the preprint server for biology, 2024.05.14.594197.

Heiling, H.M., Rashid, N.U., Li, Q., & Ibrahim, J.G. (2023). glmmPen: High Dimensional Penalized Generalized Linear Mixed Models. The R journal, 15(4), 106-28.

Lee, J.J., Kearney, J.F., Trembath, H.E., Hariharan, A., LaBella, M.E., Kharitonova, E.V., ... & Yeh, J.J. (2024). Tumor-intrinsic and Cancer-associated Fibroblast Subtypes Independently Predict Outcomes in Pancreatic Cancer. Annals of surgery, 280(4), 659-66.

Donahue, K.L., Watkoske, H.R., Kadiyala, P., Du, W., Brown, K., Scales, M.K., ... & Pasca di Magliano, M. (2024). Oncogenic KRAS-Dependent Stromal Interleukin-33 Directs the Pancreatic Microenvironment to Promote Tumor Growth. Cancer discovery, 14(10), 1964-89.

Cheng, C., Williamson, E.J., Chiu, G.T., & Han, B. (2024). Engineering biomaterials by inkjet printing of hydrogels with functional particulates. Med-X, 2(1), 9.

Dilly, J., Hoffman, M.T., Abbassi, L., Li, Z., Paradiso, F., Parent, B.D., ... & Aguirre, A.J. (2024). Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer. Cancer discovery, 14(11), 2135-61.

Benitz, S., Steep, A., Nasser, M.M., Preall, J., Mahajan, U.M., McQuithey, H., ... & Crawford, H.C. (2024). ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma. Cancer discovery, 14(11), 2162-82.

Oberstein, P.E., Dias Costa, A., Kawaler, E.A., Cardot-Ruffino, V., Rahma, O.E., Beri, N., ... & Dougan, S.K. (2024). Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor. Cancer immunology research, 12(9), 1221-35.

Somasundaram, A., & Yeh, J.J. (2024). Future of Dendritic Cell-Based Approaches in Pancreatic Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 42(26), 3067-70.

Jiang, J., Liu, Y., Qin, J., Chen, J., Wu, J., Pizzi, M.P., ... & Wang, L. (2024). METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics. Nature communications, 15(1), 7312.

Sun, L., Verhaegen, M.E., McGue, J., Olivei, A.C., Dlugosz, A.A., Frankel, T.L., & Harms, P.W. (2024). Development of a Multiplex Immunofluorescence Assay for Tumor Microenvironment Studies of Human and Murine Merkel Cell Carcinoma. Laboratory investigation; a journal of technical methods and pathology, 104(10), 102128.

Lim, D.K., Rashid, N.U., Oliva, J.B., & Ibrahim, J.G. (2024). Deeply-Learned Generalized Linear Models with Missing Data. Journal of computational and graphical statistics : a joint publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America, 33(2), 638-50.

Lee, J.J., & Yeh, J.J. (2024). Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma. The Surgical clinics of North America, 104(5), 939-50.